Deepened women’s participation in boardrooms across SGX-listed companies, Statutory Boards and IPCs with more advancing into board leadership roles

Credit: Charles Apex Leadership (Credit: Charles Forerunner / Unsplash)Forerunner / Unsplash

The Council for Board Diversity (CBD) today released the Singapore Board Diversity Review, its study on gender diversity in the boardroom of companies listed on the Singapore Exchange (SGX), at Statutory Boards and at Institutions of a Public Character (IPCs), covering more than 1,360 organisations. The study confirms the continued rise in women-held directorships across the private, public and people sectors, as well as offers new insights into board composition and director appointments.

Lynette Tan will create a better future through the space economy

Lynette Tan

In doing so, the Chairwoman & CEO of Space Faculty is equally careful to nurture Earthly corporate concerns. She gives the Council for Board Diversity this wide-ranging interview about the business of space, why you need devil’s advocates on the board, and the one question she wishes people would stop asking her.

Dr Zhou Lihan is bolstering the future of preventive healthcare

Zhou Lihan

On the eve of Mirxes’s listing application with The Stock Exchange of Hong Kong Limited, CBD sat down with the biotech’s far-sighted CEO and co-founder Dr Zhou Lihan to find out how cognitive diversity lends to his firm’s advancements in making the early detection of diseases accessible on a global scale.